Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 4 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.

Slides:



Advertisements
Similar presentations
1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Matthew J. Sheetz, MD, PhD Promoting Clear Identification of Diabetic Retinopathy.
Advertisements

The Diabetic Retinopathy Clinical Research Network
1 Diabetic macula edema. ?  Microaneurysms  CWS  Hard exudates  Beading of vessels  IRMA  NVD/NVE  DME- Types 2.
A Comparison between Fluorescein Angiography and Optical Coherence Tomography Findings in Patients with Clinically Significant Macular Edema KoriAnne Elkins.
Canadian Diabetes Association Clinical Practice Guidelines Retinopathy Chapter 30 Shelley R. Boyd, Andrew Advani, Filiberto Altomare, Frank Stockl.
“Prevention of Blindness” Is diabetic retinopathy a preventable disease? By Amr ElKamshoushy, MD.
Grand Rounds Peripheral Exudative Hemorrhagic Chorioretinopathy
Grand Rounds Eddie Apenbrinck M.D. University of Louisville School of Medicine Department of Ophthalmology & Visual Sciences 11/07/2014.
CATARACT SUEGRY AND DIABETES Indications of surgery: 1) Visual loss 2)Surveillance of retinopathy 3)Laser therapy.
Anti VEGF Options in the management of CNV 1)Observation  occult CNV also requires close follow – up.every 3 month 2) Laser coagulation 3) Surgery.
Together for Eye Health Care National Eye Health Care Service Plan for Wales 2012 – 2017 Dr Barbara Ryan Cheif Optometric Advisor.
Recovery of the β–cell function both in new and long-standing type 2 diabetic patients through long-term treatment with continuous subcutaneous insulin.
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
Vitrectomy Outcomes in Eyes with Diabetic Macular Edema, Visual Loss, and Vitreomacular Traction Sponsored by the National Eye Institute, National Institutes.
Age related macular degeneration. Summary What is ARMD? How common is it? The symptoms Two types of ARMD –Dry –Wet Tests for ARMD Treatment and managing.
The Diabetic Retinopathy Clinical Research Network Comparison of Visual and OCT Outcomes in Eyes with and without Prior Vitrectomy Receiving Anti- Vascular.
The Diabetic Retinopathy Clinical Research Network
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Personalised Eye Consultation (PEC) to improve outcomes in DR Dr Eva Fenwick (Research Fellow) Behavioural Research in Ophthalmology Prue Spencer, Project.
AGED-RELATED MACULAR DEGENERATION. (AMD) BY: Basiru Lee Leigh Mentor: Dr. Lee Angioletti Angioletti Retina Associates.
The Diabetic Retinopathy Clinical Research Network 5-Year Follow-up of a Randomized Trial Evaluating Ranibizumab Plus Prompt versus Deferred Laser for.
Titrating Insulin to Glycemic Target Judy Bowen, MD CIM Rotation September, 2006.
European Association for Vision and Eye Research – Crete, Oct 5-8, 2011 Ranibizumab for the Treatment of Exudative Age-Related Macular Degeneration Associated.
The Diabetic Retinopathy Clinical Research Network
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 3 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
The Diabetic Retinopathy Clinical Research Network Protocol I: Clinical Applications Supported through a cooperative agreement from the National Eye Institute.
Laser-Ranibizumab-Triamcinolone for DME Study DRCR.net Protocol I
Diagnosis & Management of Diabetic Eye Disease Part 1 A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education.
The Diabetic Retinopathy Clinical Research Network Expanded 2-year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt.
Diagnosis & Management of Diabetic Eye Disease Part 7 A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education.
Phase IIIb Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration PIER Study Year 1 Regillo CD,
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 6.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
Comparison of Modified ETDRS and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular Edema Sponsored by the National Eye Institute,
A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 5.
The Diabetic Retinopathy Clinical Research Network What is the Role of Laser In Treating Diabetic Macular Edema in the Era of Anti-VEGF Therapy? 1.
The Diabetic Retinopathy Clinical Research Network
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 1 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.
Efficacy of Bromfenac 0.09% in Prevention and Treatment of Pseudophakic CME When Used Preoperatively and Postoperatively by Melissa M. Cable, MD, FAAO,
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 2 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Uveitic Macular Edema Nihal Elshakankiry, MD, PhD Professor of Ophthalmology Rowayda M. Amin, MSc Assistant Lecturer of Ophthalmology Alexandria University.
Sponsored by the National Eye Institute,
The Diabetic Retinopathy Clinical Research Network DRCR.net Prompt PRP vs Ranibizumab+Deferred PRP for PDR Study Jeffrey G. Gross, M.D. – Protocol Chair.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 4.
COMPARATIVE EFFICACY OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR OEDEMA J.A. Montero, J.M. Ruiz-Moreno VISSUM, Alicante.
Improving Adherence in Type 2 Diabetes Mellitus ALLISON PETZNICK DO NOMS FAMILY MEDICINE SANDUSKY, OH.
6-year vision loss in patients newly diagnosed with clinical type 2 diabetes. What can the patients expect? Niels de Fine Olivarius Volkert Siersma Gitte.
The Diabetic Retinopathy Clinical Research Network
Old Fibrotic Vascular tissue in End-Stage Proliferative Retinopathy
How Diabetes Steals Vision from Your Patients
Prevalence of glaucoma and diabetic retinopathy by self- report and after examination in an urban low-income uninsured adult population Janis E. Winters.
The Diabetic Retinopathy Clinical Research Network
The Diabetic Retinopathy Clinical Research Network Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt vs Deferred Laser Treatment: 3-year.
Targeted Treatments and Optimised Outcomes in Diabetic Eye Disease
PROPHYLAXIS OF MACULAR EDEMA WITH PEROPERATIVE INTRAVITREAL BEVACIZUMAB IN PATIENTS WITH DIABETIC RETINOPATHY UNDERGOING PHACOEMULSIFICATION; A RANDOMIZED.
Diabetic Retinopathy Screening: A Public Health Perspective
A Paul, C Louize,S Shafquat Dudley Hospitals NHS Foundation Trust
The Diabetic Retinopathy Clinical Research Network
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
Ocular Manifestations of Diabetes
2012 ADA Clinical Practice Guidelines Therapies for DM- Type 2
SAVE Trial design: Patients with moderate to severe obstructive sleep apnea (OSA) and known CV disease were randomized in a 1:1 fashion to either CPAP.
The Diabetic Retinopathy Clinical Research Network
Dr. Paul J Olsovsky, OD An Optometry Specialist. How An Optometrist Helps You See Better? Get a modern PowerPoint Presentation that is beautifully designed.
FLAME Lecture: 13 Marshburn
The effect of sulfonylurea (glibenclamide = glyburide) and metformin therapy on the plasma HbA1c concentration in newly diagnosed T2DM subjects in UKPDS.
Diabetic Retinopathy Clinical Research Network
Presentation transcript:

Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 4 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education Tacoma, WA Adjunct Instructor, Nova Southeastern University College of Optometry Principal Investigator for the Diabetes Visual Function Supplement Study (DiVFuSS)

Patients with Closer to Optimal Glucose Control Achieved Better Visual Outcomes on Anti-VEGF Therapy Best corrected vision during 1 year follow-up according to HbA 1c level Matsuda S et al. J Diabetes Complications. 2014;28(2): CMT=central macular thickness. Note: Retrospective case series of patients treated with bevacizumab A1c < 7% resulted in an extra Line on the eye chart when using Avastin™ in DME

Patient DKS – fell through the cracks 52 yo female with T2DM x 5 years Takes lisinopril but discontinued her metformin x 6 months due to GI distress “I’ve been having some vision trouble and am here for a better glasses prescription” No eye exam x 16 mos and last A1c = 8.4% + sleep apnea but does not use CPAP

CSME/Center-Involved DME 20/200 vision

Retinal Thickening Normal < 300 microns Retinal Edema On OCT

5 Injections of Ranibizumab Later 20/40 Vision Foveal thickness now 280 microns Patient Can Legally Drive

Preventing DME Delay onset of diabetes Delay onset of diabetes Optimize metabolic control of DM Optimize metabolic control of DM Dx and treat obstructive sleep apnea Dx and treat obstructive sleep apnea If TZDs are indicated, use low dose If TZDs are indicated, use low dose Regular eye exams to reinforce evidence-based preventive strategies Regular eye exams to reinforce evidence-based preventive strategies

Preventing Vision Loss from DME Regular, dilated eye examinations Regular, dilated eye examinations 3% of newly diagnosed T2DM patients have CSME!!!!3% of newly diagnosed T2DM patients have CSME!!!! Do NOT delay until A1c is lowered!!!Do NOT delay until A1c is lowered!!! Achieve & Maintain metabolic control Achieve & Maintain metabolic control Communicate & collaborate with eye doctors (ophthalmology and optometry) Communicate & collaborate with eye doctors (ophthalmology and optometry) What is the A1c goal?What is the A1c goal? Ensure patients referred to retinal specialty for treatment keep their scheduled appointments Ensure patients referred to retinal specialty for treatment keep their scheduled appointments

Thank You! A. Paul Chous, MA, OD, FAAO